O
MDT icon

OppenheimerFunds’s Medtronic MDT Stock Holding History

OppenheimerFunds’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$138M Buy
1,520,155
+746,546
+97% +$66.8M 0.17% 132
2018
Q4 		$70.4M Buy
773,609
+483,577
+167% +$45.2M 0.1% 201
2018
Q3 		$28.5M Sell
290,032
-2,632
-0.9% -$243K 0.03% 494
2018
Q2 		$25.1M Sell
292,664
-644,808
-69% -$53.9M 0.03% 525
2018
Q1 		$75.2M Sell
937,472
-689,581
-42% -$56.9M 0.09% 232
2017
Q4 		$131M Sell
1,627,053
-83,313
-5% -$6.67M 0.16% 156
2017
Q3 		$133M Buy
1,710,366
+16,057
+0.9% +$1.33M 0.16% 150
2017
Q2 		$150M Sell
1,694,309
-85,631
-5% -$7.22M 0.19% 140
2017
Q1 		$143M Sell
1,779,940
-50,193
-3% -$3.92M 0.17% 151
2016
Q4 		$130M Sell
1,830,133
-1,158,576
-39% -$91M 0.17% 154
2016
Q3 		$258M Buy
2,988,709
+645,193
+28% +$56.2M 0.32% 82
2016
Q2 		$203M Buy
2,343,516
+113,583
+5% +$9.19M 0.27% 105
2016
Q1 		$167M Sell
2,229,933
-76,164
-3% -$5.74M 0.22% 115
2015
Q4 		$177M Buy
2,306,097
+68,568
+3% +$5.16M 0.23% 111
2015
Q3 		$150M Sell
2,237,529
-83,375
-4% -$6.14M 0.2% 126
2015
Q2 		$172M Sell
2,320,904
-372,725
-14% -$28.5M 0.2% 139
2015
Q1 		$210M Buy
2,693,629
+697,349
+35% +$52.9M 0.23% 120
2014
Q4 		$144M Sell
1,996,280
-45,930
-2% -$3.19M 0.16% 168
2014
Q3 		$127M Buy
2,042,210
+1,596,385
+358% +$102M 0.14% 182
2014
Q2 		$28.4M Buy
445,825
+34,075
+8% +$2.07M 0.03% 491
2014
Q1 		$25.3M Sell
411,750
-2,852,330
-87% -$166M 0.03% 517
2013
Q4 		$187M Sell
3,264,080
-423,420
-11% -$24M 0.23% 122
2013
Q3 		$196M Buy
3,687,500
+1,586,420
+76% +$85.4M 0.26% 105
2013
Q2 		$108M Buy
+2,101,080
New +$104M 0.16% 170

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OppenheimerFunds's MDT Position: Q1 2019 in Review

OppenheimerFunds increased its Medtronic (MDT) stake by 97% in Q1 2019, buying an estimated $66.8M and bringing the position to 1,520,155 shares worth $138M. The position accounts for 0.17% of the portfolio, ranked #132.

OppenheimerFunds first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $258M in Q3 2016. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • OppenheimerFunds held 1,520,155 shares of Medtronic worth $138M as of Q1 2019.
  • OppenheimerFunds bought 746,546 Medtronic shares in Q1 2019, an estimated $66.8M.
  • Medtronic made up 0.17% of OppenheimerFunds's portfolio in Q1 2019, its #132 holding.
  • OppenheimerFunds first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Medtronic position peaked at $258M in Q3 2016.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.